Post Content
-
Management attributes the 2025 performance surge to a successful three-year strategic transformation that addressed labor market challenges by aligning clinical capacity with preferred payers.
-
The ‘Preferred Payer’ strategy is the primary driver of margin stabilization, as it directs staffing toward partners willing to engage in enhanced reimbursement and value-based agreements.
-
Revenue growth in Private Duty Services (PDS) was fueled by a 10.2% increase in revenue per hour, reflecting the shift toward higher-reimbursement preferred payer volumes.
-
Home Health outperformance was driven by a disciplined focus on an episodic-only model, which now accounts for 78% of the segment’s mix and supports double-digit organic growth.
-
Medical Solutions results were temporarily bolstered by a $2.5 million to $3 million reserve release from improved cash collections, though the segment is undergoing a similar preferred payer pivot.
-
Management emphasizes that the industry faces a capacity constraint rather than a demand problem, with government and MCO partners actively seeking home-based solutions to reduce total care costs.
-
The 2026 guidance assumes a transition to ‘normalized’ growth, with PDS rate enhancements expected to moderate to high single-digits (6-8 states) compared to 10 states in 2025.
-
Management targets expanding preferred payer agreements to 38 in PDS, 50 in Home Health, and 25 in Medical Solutions by the end of 2026.
-
The Medical Solutions segment is expected to maintain mid-single-digit growth in the first half of 2026 before returning to double-digit growth following the completion of efficiency initiatives.
-
Strategic priorities for 2026 include implementing AI and automation for operational productivity and pursuing M&A to densify current markets and enter new geographies like the ‘Heartland’ states.
-
Financial guidance for 2026 excludes the impact of the Family First acquisition, which is expected to close in late Q2 pending regulatory approvals.
-
The acquisition of Family First Home Care for $175.5 million (7.5x post-synergy EBITDA) is intended to densify the Florida market and expand geographic reach to every county in the state.
-
The 53rd week in the 2025 fiscal calendar provided a non-recurring boost to revenue and EBITDA that will not repeat in the 2026 comparable periods.
-
California remains a strategic outlier with no rate increases included in the state’s 2026-2027 budget; management has modeled no material improvement for this market in their guidance.
-
Net leverage reached approximately 4x at year-end 2025, with management intending to maintain or slightly reduce this level while funding acquisitions through cash on hand and existing facilities.
Terms and Privacy Policy